
Stanford University enrolls first subject in HEAL (Human Upper Extremity Acebilustat Lymphedema) trial
Celltaxis LLC is the sponsoring company developing the investigational drug Acebilustat NEW YORK, NY, USA, August 18, 2022 /EINPresswire.com/ -- In the last two years, the U.S. Department of Labor, Health and Human Services, and Education, and Related …